CLINICAL_TRIALS
trial_result
· 2009-12-07
Clinical Trial Update: LANTUSTITR: Insulin Glargine in Type 2 Diabetes Mellitus [Phase 4]
Summary
A Phase 4 trial of insulin glargine (Lantus) for type 2 diabetes mellitus has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: TERMINATED